Clewell Harvey J, Andersen Melvin E, Blaauboer Bas J
The Hamner Institutes for Health Sciences, 6 Davis Drive, Research Triangle Park, NC 27709, USA.
Toxicol Lett. 2008 Aug 15;180(2):100-9. doi: 10.1016/j.toxlet.2008.06.002. Epub 2008 Jun 8.
This paper describes the evolution of chemical risk assessment from its early dependence on generic default approaches to the current situation in which mechanistic and biokinetic data are routinely incorporated to support a more chemical-specific approach. Two methodologies that have played an important role in this evolution are described: mode-of-action evaluation and physiologically based biokinetic (PBBK) modelling. When used together, these techniques greatly increase the opportunity for the incorporation of biokinetic and mechanistic data in risk assessment. The resulting risk assessment approaches are more appropriately tailored to the specific chemical and are more likely to provide an accurate assessment of the potential hazards associated with human exposures. The appropriate application of PBBK models in risk assessment demands well-formulated statements about the chemical mode of action. It is this requirement for an explicit, mechanistic hypothesis that gives biologically motivated models their power, but at the same time serves as the greatest impediment to the acceptance of a chemical-specific risk assessment approach by regulators. The chief impediment to the regulatory acceptance and application of PBBK models in risk assessment is concern about uncertainties associated with their use. To some extent such concerns can be addressed by the development of generally accepted approaches for model evaluation and quantitative uncertainty analysis. In order to assure the protection of public health while limiting the economic and social consequences of over-regulation, greater dialogue between researchers and regulators is crucially needed to foster an increased use of emerging scientific information and innovative methods in chemical risk assessments.
本文描述了化学风险评估的演变,从早期依赖通用默认方法到目前的情况,即机械和生物动力学数据被常规纳入以支持更具化学特异性的方法。文中介绍了在这一演变过程中发挥重要作用的两种方法:作用模式评估和基于生理学的生物动力学(PBBK)建模。当这两种技术一起使用时,它们大大增加了在风险评估中纳入生物动力学和机械数据的机会。由此产生的风险评估方法更适合特定的化学物质,更有可能准确评估与人类接触相关的潜在危害。PBBK模型在风险评估中的适当应用需要关于化学作用模式的精心制定的陈述。正是这种对明确的机械假设的要求赋予了具有生物学动机的模型力量,但同时也成为监管机构接受化学特异性风险评估方法的最大障碍。监管机构在风险评估中接受和应用PBBK模型的主要障碍是对其使用相关不确定性的担忧。在某种程度上,这种担忧可以通过开发普遍接受的模型评估和定量不确定性分析方法来解决。为了在限制过度监管的经济和社会后果的同时确保公众健康得到保护,研究人员和监管机构之间需要进行更多对话,以促进在化学风险评估中更多地使用新兴科学信息和创新方法。